AML3D Limited Overview
AML3D is an Adelaide-founded original equipment manufacturer (OEM) of large-format industrial metal 3D printers, built around its patented Wire Arc Additive Manufacturing process (trademarked WAM®), its ARCEMY® printer family, and its WAMSoft®/AMLSoft software stack. The process uses an electric arc to melt certified welding wire and deposit metal layer by layer, producing near-net-shape parts in alloys such as nickel-aluminium bronze, copper-nickel, titanium, nickel alloys and steels. After a slow post-IPO period serving Asian and Australian marine and resources customers, the company pivoted in 2023 to a "US Scale Up" strategy targeting the US Navy's Maritime Industrial Base, where casting and forging bottlenecks constrain submarine and shipbuilding programs. That pivot has produced orders from Newport News Shipbuilding (HII), Austal USA, BlueForge Alliance, the Tennessee Valley Authority and FasTech. AML3D now combines system sales, contract part printing, leasing and software/service revenue, operates technology centres in Adelaide and Stow, Ohio, and is preparing a UK hub to serve AUKUS and European defence demand.
Company's own description (FY26 Annual Report)
In its FY26 Directors' Report, AML3D characterises itself as a business spanning welding, robotics, metallurgy and software that uses automated wire-fed 3D printing in a large free-form environment to produce metal components and structures. It describes WAM® as a cost-effective way to make large, high-performance metal parts across titanium, nickel and steel alloy families, combining an electric arc heat source with wire feedstock to deposit sequential weld layers into near-net-shape components. Its proprietary WAMSoft® software combines metallurgical science and engineering design to automate the process, choosing optimal tool paths from a library of weld-bead geometries according to material, wall thickness, geometry and size.
The stated principal activities in FY26 were: (a) designing and building ARCEMY® 3D printing modules for sale or lease; (b) designing and producing 3D-printed parts using WAM and developing that technology; and (c) research and development to refine products and find new applications.
Revenue model
The FY26 Annual Report identifies three revenue sources:
-
ARCEMY® system sales — customers buy printers for in-house fabrication or research/education.
-
Contract manufacturing ("print revenue") — AML3D prints parts for customers on its own ARCEMY fleet (eight company-owned systems across Australia and the US per FY26 results commentary).
-
Licensing, service and technical support — recurring software licences, maintenance and support for installed systems; plus equipment lease income (e.g., two ARCEMY units on lease to Laser Welding Solutions in the US).
Source: FY26 Annual Report, Operating and Financial Review. Implied A$ amounts are analyst calculations from disclosed percentages.
Product vs service vs subscription vs licensing mix (analyst characterisation): FY26 was roughly 70% capital equipment (systems), ~22% services (contract printing), ~6% leasing, and ~2% software/licensing/maintenance on a revenue-including-lease basis. The business is therefore still overwhelmingly a lumpy capital-goods vendor; the recurring "razor-blade" layer (software licences, service contracts, consumable wire feedstock) is strategically emphasised but financially immaterial so far.
Value-chain position
AML3D sits at three points of the metal manufacturing value chain:
Equipment OEM: it integrates industrial robots, welding power sources, wire feed, enclosures, sensors and its own control/path-planning software into turnkey ARCEMY cells. Core components (robots, welding sources) are bought in; the IP lies in the process, metallurgy, qualification data and software.
Part producer: it competes directly with foundries and forge shops by printing near-net-shape parts (e.g., nickel-aluminium bronze submarine components) that are then machined to final dimensions.
Qualification partner: it generates material and process qualification data (alloy characterisation, test blocks) that customers such as the US Navy and BAE Systems need before deploying additively manufactured parts. This "qualify-then-sell-systems" pathway is how it entered both the US and UK markets.
Customer types and end-markets
| Customer type | Named examples (from disclosures) | End-market |
|---|---|---|
| Defence prime shipbuilders | Newport News Shipbuilding (HII); Austal USA; BAE Systems (UK) | Naval shipbuilding / submarines |
| Defence industrial-base integrators | BlueForge Alliance (US non-profit integrator funded by the Department of Defense) | Submarine Industrial Base |
| Navy-operated / Navy-funded facilities | US Navy Additive Manufacturing Centre of Excellence, Danville, Virginia (operated by Austal USA) | Naval sustainment |
| Tier-2/3 component suppliers | Laser Welding Solutions (US); FasTech LLC (US) | Defence, aerospace, energy |
| Utilities | Tennessee Valley Authority (TVA) | Power generation maintenance/repair |
| Universities / research | Curtin University (Perth, WA) | Research, AUKUS precinct, satellite manufacturing |
| Historic commercial clients | Keppel (Singapore marine; Panama chock trial 2020) | Marine/offshore |
| Distribution / resellers | Phillips Corporation (US value-added reseller from April 2023); Arc Additive Limited (Scotland; UK & Europe distributor from mid-2025) | Channel |
Independent characterisation
AML3D is best understood as a defence-led, niche capital-equipment company in the very early stage of commercial scale-up. Its addressable market is defined less by "3D printing" generically than by the specific economics of replacing long-lead castings and forgings for large, low-volume, high-value metal parts — exactly the bottleneck in US submarine production. Its competitive edge rests on (i) being early into US Navy qualification programs, (ii) material know-how in marine alloys (NAB, CuNi), (iii) class-society certifications (DNV, Lloyd's Register) and AS9100D, and (iv) a domestic US build facility that addresses ITAR/data-handling sensitivities. Its weaknesses are scale (A$12.5m revenue), extreme customer concentration (87% of 1H26 revenue from US customers, dominated by a handful of defence buyers), lumpy point-in-time revenue recognition, and a still-loss-making cost base reliant on equity funding to date.
Strategy
Stated strategy (FY26 Annual Report themes, paraphrased)
The board describes a three-phase growth strategy:
Phase 1 — US Defence ("US Scale Up"): convert early US Navy validation into system orders and component work within the Maritime Industrial Base (submarines, aircraft carriers, surface fleet, munitions), positioning ARCEMY as an alternative to constrained casting and forging supply.
Phase 2 — Adjacent markets (medium term): use the US Navy track record to enter adjacent US defence sectors, US industrial manufacturing (utilities, aerospace, energy, oil & gas, marine), and other major defence markets, starting with the UK and Europe.
Phase 3 — AUKUS and Asia-Pacific (longer term): use the trilateral footprint (Adelaide/Perth, Stow, UK) to support AUKUS manufacturing and sustainment, and use Australia as a springboard into Asia-Pacific industrial markets.
Ongoing operating priorities (Directors' Report): partnerships in high-margin sectors (defence, oil and gas, marine); selling ARCEMY modules for in-house capability; growing recurring software licensing, service and maintenance revenue; continued R&D including lowering energy use and carbon footprint of WAM; building global profile through universities and industry partners.
Initiatives announced in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| A$30m equity placement | Nov–Dec 2024 | 157.9m shares at A$0.19; use of funds: ~A$12m US capacity, ~A$5m UK/Europe, up to A$3m software/technology, balance working capital | Completed |
| Stow, Ohio technology centre | Dec 2024 / Jun 2025 | US build and qualification facility | Operational |
| Stow capacity doubling | Announced late 2024 | A$12m fully funded; to double US capacity | In progress (A$2.12m spent at 30 Jun 2026); FY27 spend ~A$10m implied |
| UK / European Technology Centre | Allocated 2024; reiterated 2026 | A$5m; triggered by signing initial two UK ARCEMY orders | Pending (first UK order in "advanced negotiation") |
| UK/Europe distribution | Jul–Aug 2025 | Arc Additive Limited (Scotland), non-exclusive, two years | Active |
| US advocacy program | 3Q–4Q FY26 | Larissa Smith and RADM (ret.) David Goggins appointed as US board advisors | Active |
| Portable/containerised ARCEMY | FY26 | First unit deployed at US Navy AM CoE | Commercialised |
| Expansion into US utilities and industrial | FY25–FY26 | TVA and FasTech systems commissioned | Delivered |
| AUKUS positioning in Western Australia | FY26 | Curtin enterprise system as satellite facility near Henderson AUKUS precinct | Delivered |
| ARCEMY Increased Deposition Rates (AIDR) R&D | Ongoing | A$2.24m project, co-funded 1:1 by SA Government Economic Recovery Fund; multi-robot and twin-wire feeds | In progress |
| Software platform investment (AMLSoft) | FY25–FY26 | Expanded dedicated software team | In progress |
| Investor relations engagement | Apr 2026 | 2m shares issued to S3 Consortium for IR services Jun 2026 – Jun 2028 (A$375k, escrowed) | Active |
Medium-term targets and guidance
AML3D does not publish quantitative earnings guidance. Management's forward-looking statements include: the board expects FY27 to be another record year; A$16.8m of contracted orders carried into FY27 (vs A$9m into FY26); an estimated A$78m global sales pipeline; four further NNS systems (~A$9.9m) for delivery in early 2027; and US Navy demand signals of up to ~100 systems and ~3,400 parts by 2030 (per the June 2026 commissioning release summary). The FY26 interim presentation referred to an approximately A$200m opportunity for AML3D (context not fully extracted). No ESG targets or cost-reduction program with numerical targets have been announced.
Products & Services
AML3D does not operate separate business segments, so the catalogue is organised by hardware, software and services. Pricing is not published as a list; indicative system values are inferred from disclosed order values.
Core process technology
| Offering | Description | Key capabilities | Status |
|---|---|---|---|
| WAM® (Wire Additive Manufacturing / Wire-arc Additive Manufacturing) | Patented process using an electric arc and certified welding wire to deposit near-net-shape metal parts layer by layer | Large free-form parts; titanium, nickel, steel, aluminium and bronze/copper alloys; lower waste than billet machining; much shorter lead times than casting/forging (e.g., CuNi tailpiece in <5 weeks vs 17 months) | Commercial; patents granted in Australia (AU 2019251514), Europe, India, Japan, NZ, Korea, Singapore, Malaysia |
ARCEMY® hardware family
| Product | Description | Target customer | Indicative value (from disclosed orders) | Named deployments |
|---|---|---|---|---|
| ARCEMY® Education | Entry configuration for teaching/training | Universities, TAFEs | — | — |
| ARCEMY® Small / Small Edition | Compact cell for R&D and smaller parts | Universities, R&D labs, suppliers | Not disclosed (Curtin's existing "small R&D system") | Curtin University |
| ARCEMY® Small Edition — Portable (containerised) | Small edition mounted in a 20-foot shipping container for rapid redeployment near the point of need | Navy sustainment, field/expeditionary manufacturing | ~A$1.2m (Austal USA order) | US Navy AM CoE, Danville VA (May 2026) |
| ARCEMY® 2600 Edition | Mid-size industrial system | Tier-2 defence suppliers | ~A$1.1m (LWS purchase) | Laser Welding Solutions (1 purchased, 2 leased) |
| ARCEMY® Enterprise / Enterprise Edition | Industrial production cell | Universities, industrial users | ~A$1.0m (Curtin) | Curtin University, Perth (commissioned 3Q FY26) |
| ARCEMY® X (incl. X-Edition 6700) | Largest standard system for large-scale parts | Shipbuilders, utilities, large suppliers | ~A$1.0m (first BlueForge 2023), ~A$1.7m (FasTech), ~A$2.27m (TVA), ~A$2.25m average (NNS: A$4.5m for 2; A$9.9m for 4) | BlueForge/Oak Ridge; TVA; FasTech; NNS (2 commissioned Jun 2026, 4 due early 2027) |
| Custom large-scale ARCEMY | Bespoke builds beyond the X envelope | Prime shipbuilders | ~A$2.2m (Austal USA 2023) | Austal USA Advanced Technologies |
The FY26 results presentation lists the ARCEMY range spanning the following editions. Detailed specifications (build envelope, deposition rate) were not extractable from the presentation; indicative values below come from order announcements.
Analyst note: the step-up in average order value from ~A$1.0m (2023) to ~A$2.25–2.5m per X-class system (FY26) shows the mix moving towards larger, customised, higher-value machines. Six of the 15 US defence-related system orders are for a single customer (NNS).
Software
| Product | Description | Commercial model |
|---|---|---|
| WAMSoft® | Proprietary software converting CAD models into qualified weld paths, using a library of bead geometries chosen by material, thickness, geometry and size | Licensed with systems; annual licence fees (amounts not disclosed) |
| AMLSoft | Operating system that runs ARCEMY hardware and captures real-time production data (introduced in 2026 marketing materials) | Bundled/licensed; part of the A$3m software investment funded by the 2024 placement |
| Process monitoring / IoT | ARCEMY described as IoT/Industry 4.0 enabled, capturing production data for qualification | Bundled |
Services
| Service | Description | Example |
|---|---|---|
| Contract part manufacturing ("print revenue") | Printing near-net-shape components on AML3D-owned ARCEMY systems in Adelaide and Stow | A$2.61m BlueForge order for five out-of-production NAB submarine components (10-month program from 4Q FY26); earlier A$2m submarine part order (2023); CuNi Virginia-class tailpieces (2025) |
| Material qualification and test-block programs | Alloy characterisation, test blocks, qualification prints for new defence/industrial applications | BlueForge NAB and CuNi programs (2023); BAE Systems ~A$1.2m material feasibility and test-block program (UK) |
| Wire feedstock supply | Supply of certified welding wire consumables | BAE Systems: 8.5 tonnes NAB wire (A$0.83m, Apr 2025) |
| System leasing | Lease of ARCEMY units with purchase options | Two ARCEMY 2600 systems on lease to LWS |
| Service, maintenance and technical support | Annual service contracts with system sales | LWS purchase included initial one-year service contract |
| Engineering/design for AM | Redesign of parts for WAM | Referenced in company descriptions; revenue not separately disclosed |
| System upgrades | Upgrading third-party/older systems to ARCEMY standard | Contract with an Australian defence and industry supplier (FY25) |
Certifications underpinning the portfolio
AS9100D:2016 aerospace quality management accreditation; DNV Additive Manufacturing Facility accreditation; Lloyd's Register wire-arc AM facility certification. Management states DNV and Lloyd's Register together cover close to two-thirds of the global market for class-certified marine components (FY26 AR).
Financial Narrative
Sources: FY26 Annual Report (five-year performance table and audited FY26/FY25 statements); FY25 Preliminary Final Report; TipRanks (aggregator, used only for FY22–FY24 gross profit and D&A and flagged). EBITDA is as defined by the company (excludes interest income). FY25 figures are restated unless noted.
Income statement: notes and sources
Notes: FY24 gross profit and FY22–FY24 D&A from TipRanks (aggregator). FY23 gross profit is shown by TipRanks as negative (−A$2.76m), which likely reflects a different cost classification; it is omitted here as unverifiable. FY25 net loss as originally reported was A$7.40m (pre-restatement); FY24 pre-tax loss per TipRanks was A$4.35m versus the company's A$4.17m after-tax loss (difference likely R&D tax treatment). AML3D pays no income tax; unrecognised carried-forward tax benefits were A$6.30m (tax-effected) at 30 June 2026.
Margins (% of revenue including lease income; blank = not meaningful/disclosed)
Revenue CAGR: FY22–FY26 (4 years) = 57.7% p.a.; FY24–FY26 (2 years) = 30.5% p.a. Company-reported gross margin for FY26 is 63% (vs 68% in FY25).
Balance sheet
Commentary: The balance sheet is essentially unlevered. The FY25 jump in equity reflects the A$30m placement (A$28.0m net cash proceeds in FY25). A$10m placed on term deposit at FY25 was largely returned to cash in FY26, which is why reported cash rose while total liquid funds (cash plus term deposits) fell from A$30.5m to A$26.75m. Receivables more than doubled to A$4.30m on 2H-weighted deliveries (doubtful-debt expense of A$0.18m was booked in FY26, the first in the comparative period).
Cash flow
Commentary: Operating cash burn widened in FY26 despite the improved P&L, because receivables built up at year-end, customer deposits (contract liabilities) were drawn down, and payments to suppliers and employees rose 34% to A$16.3m as the US was staffed and inventory built for NNS systems. FY26 equity inflow came from option exercises at A$0.10 (27.7m shares, ~A$2.7m), not new placements. At 30 June 2026, A$2.12m of the A$12m Stow expansion budget had been spent, implying ~A$9.9m of committed US capex remains, plus the A$5m UK centre (contingent).
Trend commentary
Revenue. The five-year path has three distinct phases: FY22–FY23 (A$2.0m → A$0.6m) when the Asia/Australia commercial model stalled; FY24 (A$7.3m) when the US Navy pivot produced the first wave of BlueForge, Austal and LWS orders; and FY25–FY26 when revenue first plateaued (A$7.4m, as Stow was established) and then stepped up 69% to A$12.5m on NNS, TVA, FasTech, Austal portable and submarine parts deliveries. Revenue is recognised mostly at a point in time on commissioning (KPMG notes A$11.48m of FY26 revenue was point-in-time and flagged cut-off risk as a key audit matter), so half-year revenue swings are large: 1H26 was down 30% to A$3.25m because of raw-material delays and project extensions, while 2H26 delivered ~A$9.2m.
Gross margin. Margins of 62–68% are high for capital equipment and reflect software/IP value embedded in system pricing. The FY26 dip to 63% stems from mix (larger custom X systems, more printing work) and the doubling of COGS to A$4.7m.
Profitability inflection. 2H26 EBITDA of +A$0.61m is the first positive half in company history. Full-year EBITDA loss narrowed 35% to A$4.23m. The improvement was helped by non-operating items that should be watched: interest income of A$1.01m (on cash from the placement, excluded from EBITDA but included in net loss) and an R&D tax offset of A$1.10m (up from A$0.23m, included in EBITDA). Excluding the R&D offset and grants, FY26 underlying EBITDA would have been roughly −A$5.8m.
Share-based payments. Equity-settled share-based payments were A$1.03m (23% of the pre-tax loss) in FY26 and A$1.42m in FY25. Directors receive annual option grants without performance hurdles, which inflates reported losses and dilutes holders.
Balance-sheet resilience. With A$26.7m cash, no borrowings and a FY26 free cash outflow of A$6.4m, the company has around four years of runway at the FY26 burn rate before committed capex, or roughly two to three years after the remaining ~A$10m Stow program and potential A$5m UK centre if operations do not move to cash breakeven. Management states the balance sheet funds both investment programs.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Role | Source |
|---|---|---|---|
AML3D Limited | Australia | Parent; Adelaide/Edinburgh technology centre, R&D, system builds, contract printing | FY26 AR |
AML3D USA Inc. | United States (Ohio operations) | US technology centre at Stow, Ohio; system builds and qualification prints for US customers; President Pete Goumas | FY26 AR |
AML Technologies (Asia) Pte Limited | Singapore | Legacy Asian sales/contract-manufacturing vehicle from IPO strategy; current activity level not disclosed | FY26 AR |
UK entity | United Kingdom | Not yet established; A$5m allocated for a UK/European Technology Centre, contingent on initial UK ARCEMY orders | FY26 AR |
Revenue stream (AUD Mn)
| Revenue stream (AUD Mn) | FY24 | FY25 | FY26 |
|---|---|---|---|
Revenue excluding lease income (AUD Mn) | — | 6.67 | 11.76 |
Equipment lease income (AUD Mn) | — | 0.72 | 0.71 |
Total revenue including lease income (AUD Mn) | 7.32 | 7.39 | 12.47 |
ARCEMY units and associated parts (AUD Mn, derived 75%) | — | — | 8.82 |
Print / contract manufacturing (AUD Mn, derived 23%) | — | — | 2.70 |
Licence and recurring fees within revenue (AUD Mn, derived ~2%) | — | — | 0.24 |
Valuation Snapshot
| Metric | Value | Basis |
|---|---|---|
Revenue ex-lease growth YoY | +76% | FY26 AR (A$11.76m vs restated A$6.67m) |
Revenue incl. lease growth YoY | +69% (company rounds to 70%) | A$12.47m vs A$7.39m |
Lease income growth YoY | −1% | A$0.713m vs A$0.720m |
Systems share of revenue (ex-lease) | 75% | FY26 AR |
Print share of revenue (ex-lease) | 23% | FY26 AR |
First-half / second-half split | 1H26 A$3.25m (−30% YoY); 2H26 ~A$9.2m (derived) | FY26 Interim Report; analyst derivation |
Income Statement and Per-Share Data
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Revenue including lease income (AUD Mn) | 2.01 | 0.63 | 7.32 | 7.39 | 12.47 |
Cost of goods sold (AUD Mn) | — | — | — | 2.34 | 4.67 |
Gross profit (AUD Mn) | — | — | 4.52 | 5.05 | 7.80 |
EBITDA (AUD Mn) | -4.16 | -4.79 | -3.31 | -6.54 | -4.23 |
Depreciation and amortisation (AUD Mn) | 0.72 | 0.69 | 0.82 | 0.93 | 1.10 |
Operating income / EBIT (AUD Mn, EBITDA less D&A) | -4.88 | -5.48 | -4.13 | -7.48 | -5.34 |
Pre-tax income (AUD Mn) | -4.90 | -5.44 | -4.17 | -7.25 | -4.48 |
Net income (AUD Mn) | -4.90 | -5.44 | -4.17 | -7.25 | -4.48 |
Basic EPS (A$ cents) | -3.3 | -2.7 | -1.7 | -1.6 | -0.8 |
Diluted EPS (A$ cents) | -3.3 | -2.7 | -1.7 | -1.6 | -0.8 |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Margin (%)
| Margin (%) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Gross margin (%) | — | — | 61.7 | 68.4 | 62.5 |
EBITDA margin (%) | -206.4 | -755.4 | -45.2 | -88.5 | -33.9 |
Operating (EBIT) margin (%) | -242.2 | -864.2 | -56.4 | -101.2 | -42.8 |
Net margin (%) | -243.0 | -856.9 | -56.9 | -98.2 | -35.9 |
Cost / income line (AUD Mn)
| Cost / income line (AUD Mn) | FY25 | FY26 |
|---|---|---|
Director and employee benefits (AUD Mn) | 6.02 | 6.65 |
Professional fees (AUD Mn) | 1.47 | 1.88 |
Research and development expense (AUD Mn) | 1.06 | 1.37 |
Equity-settled share-based payments (AUD Mn) | 1.42 | 1.03 |
Travel and accommodation (AUD Mn) | 0.36 | 0.48 |
R&D tax offset income (AUD Mn) | 0.23 | 1.10 |
Government grants income (AUD Mn) | 0.19 | 0.43 |
Interest received (AUD Mn) | 0.41 | 1.01 |
Balance Sheet
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | — | — | 39.35 | 39.48 |
Cash and cash equivalents (AUD Mn) | 2.93 | 4.53 | 7.79 | 20.40 | 26.67 |
Term deposits / other financial assets (AUD Mn) | — | — | — | 10.08 | 0.08 |
Bank borrowings (AUD Mn) | — | — | — | 0.00 | 0.00 |
Lease liabilities — current (AUD Mn) | — | — | — | 0.22 | 0.28 |
Lease liabilities — non-current (AUD Mn) | — | — | — | 1.57 | 1.29 |
Total debt incl. leases (AUD Mn) | — | — | — | 1.79 | 1.57 |
Net cash incl. term deposits, after leases (AUD Mn) | — | — | — | 28.69 | 25.19 |
Total equity (AUD Mn) | 6.63 | 6.93 | 9.99 | 32.23 | 32.00 |
Goodwill and intangibles (AUD Mn) | — | — | — | 0.05 | 0.04 |
Working capital (AUD Mn) | — | — | — | 29.08 | 28.32 |
Contract liabilities (customer deposits, AUD Mn) | — | — | — | 3.37 | 2.93 |
Trade and other receivables (AUD Mn) | — | — | — | 1.75 | 4.30 |
Inventory (AUD Mn) | — | — | — | 1.35 | 1.58 |
Cash Flow
| Metric (AUD Mn) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Receipts from customers (AUD Mn) | — | — | — | 8.67 | 10.42 |
Operating cash flow (AUD Mn) | — | — | — | -2.89 | -4.65 |
Capex — plant and equipment (AUD Mn) | — | — | — | 2.09 | 1.77 |
Capex — intangibles (AUD Mn) | — | — | — | 0.03 | 0.02 |
Free cash flow (AUD Mn) | — | — | — | -5.00 | -6.44 |
Equity raised, net (AUD Mn) | — | — | — | 28.03 | 2.71 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY25 | FY26 | Method |
|---|---|---|---|
ROE (%) | -34.4 | -14.0 | Net loss / average equity |
ROA (%) | -18.4 | -11.4 | FY25 on closing assets (FY24 assets n.d.); FY26 on average assets |
ROIC (%) | — | -77.4 | EBIT / (equity + leases − cash − term deposits); FY25 invested capital near zero, not meaningful |
Current ratio (x) | 6.73 | 6.00 | Current assets / current liabilities |
Debt / equity (x, leases only) | 0.06 | 0.05 | No bank debt |
Net debt / EBITDA (x) | — | — | Net cash position; EBITDA negative — not meaningful |
Interest coverage (x) | — | — | EBIT negative — not meaningful; interest income exceeds lease interest |
Asset turnover (x) | 0.19 | 0.32 | Revenue / average (FY26) or closing (FY25) assets |
DSO (days) | 87 | 126 | Receivables / revenue × 365 (receivables gross of GST; year-end loaded) |
DIO (days) | 211 | 123 | Inventory / COGS × 365 |
DPO (days) | 176 | 155 | Trade payables / COGS × 365 (payables include opex — overstates DPO) |
Cash conversion cycle (days) | 122 | 94 | DSO + DIO − DPO (approximate) |
Region (% of Revenue) Overview
| Region (% of revenue) | FY26 |
|---|---|
United States share of revenue, first half only (%) | 87 |
Australia and rest of world share, first half only (%) | 13 |
Country Overview
| Country | FY26 activity | Trend |
|---|---|---|
United States | NNS (6 systems ordered, 2 commissioned), TVA commissioned, FasTech commissioned, Austal portable system, A$2.61m submarine parts, LWS leases | Fastest-growing; the core of revenue and the order book |
Australia | Curtin University enterprise system (A$1m); Adelaide supports UK/BAE programs and R&D; system upgrade contract | Strategic (AUKUS) but small revenue |
United Kingdom | BAE Systems feasibility/test-block program (~A$1.2m cumulative incl. earlier feedstock contract); confidential component work for a UK defence prime; advanced negotiations for first UK ARCEMY | Emerging; potential medium-term driver |
Singapore / Asia | Legacy subsidiary; no FY26 revenue disclosed | Declined post-2022 as strategy pivoted to the US |
Share Price and Market Valuation
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Share price at 30 June (AUD) | 0.052 | 0.048 | 0.095 | 0.200 | 0.130 |
Market capitalisation at 30 June (AUD Mn) | 7.82 | 11.31 | 35.82 | 107.55 | 73.77 |
Total shareholder return (%) | -75 | -8 | 98 | 111 | -35 |
Shares on issue at 30 June (m) | 150.46 | 235.55 | 377.10 | 537.74 | 567.45 |
Share Price & Returns
| Horizon | Reference price | Change |
|---|---|---|
Calendar YTD 2026 | A$0.175 (start 2026) | −41% |
FYTD 2027 (since 1 Jul 2026) | A$0.13 | −21% |
~1 year | ~A$0.24 (early Oct 2025) | ~−57% |
~3 years (vs 30 Jun 2023 close A$0.048) | A$0.048 | ~+114% |
~5 years (vs 30 Jun 2021 close A$0.205) | A$0.205 | ~−50% |
Since IPO (A$0.20, Apr 2020) | A$0.20 | ~−49% |
Valuation Multiples
| Multiple | AML3D | Comment |
|---|---|---|
Market capitalisation | ~A$58.2m | 567.4m shares |
Enterprise value | ~A$33.1m | Market cap − A$26.67m cash + A$1.57m leases (term deposits A$0.08m ignored) |
EV/Sales | ~2.7x | On A$12.47m FY26 revenue |
P/B | ~1.8x | On A$32.0m equity |
Analyst Ratings & Targets
| Broker / source | Rating | Target | Date | Notes |
|---|---|---|---|---|
Shaw and Partners | — | A$0.30 (cut from A$0.40) | Jul 2026 | Now expects A$100m revenue by FY32 (previously FY30) |
TipRanks-reported analyst | Buy | A$0.40 | Aug 2025 | Likely the pre-cut Shaw view |
Simply Wall St consensus | — | — | Aug 2025 | Analysts forecast ~43% p.a. revenue growth over three years; FY25 revenue missed estimates by ~12% |
Capital Markets
| Item | Status |
|---|---|
Dividend history | No dividends ever declared or paid; no dividend reinvestment plan |
Dividend policy | Not formally articulated; growth reinvestment implied |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Analyst Conclusions
Management guidance (qualitative)
-
Board "confident FY27 will be another record year" (i.e., revenue above A$12.47m).
-
A$16.8m contracted orders entering FY27, including ~A$9.9m for four NNS systems due early 2027 and the 10-month A$2.61m submarine parts program.
-
Global sales pipeline estimated at A$78m; US pipeline includes potential orders representing a further step-up in system value and quantity.
-
First UK ARCEMY order in advanced negotiation; UK centre triggered upon two UK orders.
-
Stow capacity doubling to continue through FY27.
Consensus expectations
No published consensus beyond Shaw and Partners' view (A$100m revenue by FY32, implying roughly 41% CAGR from FY26) and Simply Wall St's 2025 aggregate (~43% p.a. revenue growth). Earnings consensus is not publicly disclosed.
Bull case
-
Backlog conversion plus pipeline: A$16.8m in hand already covers ~135% of FY26 revenue; converting even a quarter of the A$78m pipeline would support FY27 revenue well above A$20m.
-
Operating leverage proven: 2H26 EBITDA turned positive at an annualised ~A$18m revenue run rate; with 63% gross margins, incremental revenue drops through strongly.
-
Strategic scarcity: with six systems at NNS and three at the Navy's AM CoE, AML3D is a de facto reference supplier in a policy-prioritised supply chain, and EV of ~A$33m is under 3x trailing sales.
Bear case
-
Concentration and funding risk: a pause in NNS or BlueForge spending would leave little to fill the gap — 1H26 already showed revenue can fall 30% on timing alone.
-
Cash burn and dilution: FCF of −A$6.4m in FY26 plus ~A$15m of committed/contingent capex could exhaust a substantial share of the A$26.7m cash within two years if growth stalls; at a depressed share price, any raise would be highly dilutive.
-
Competitive and governance overhangs: larger WAAM players, alternative deposition technologies, the founder's near-complete exit, a restatement, and unhurdled director options may keep a discount on the stock.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing |
|---|---|
| 1Q FY27 quarterly: receipts, new orders, cash | Late Oct 2026 |
| 2026 AGM (director option grants, re-elections, remuneration vote) | ~Nov 2026 |
| First UK ARCEMY order and UK centre decision | FY27 |
| Delivery/commissioning of four NNS systems | Early CY2027 |
| 1H FY27 results: will revenue avoid another first-half dip? | Feb 2027 |
| New large US Navy MIB system orders (LOI conversion) | Ongoing |
| Stow capacity doubling completion and capex spend | FY27 |
| CTO succession / technical leadership | FY27 |
| CEO contract renewal (3-year term from Sep 2023) | ~Sep 2026 onward |
| US defence appropriations and BlueForge funding flows | FY27 (US FY2027 budget) |
| 16.1m A$0.30 options expiring 30 Jun 2027 (likely lapse at current prices) | Jun 2027 |
Analyst verdict
AML3D has crossed a genuinely important threshold. After five years in which revenue oscillated between A$0.6m and A$7.4m and losses of A$4–7m a year were funded by equity, FY26 delivered a 69% revenue increase to A$12.47m, gross margins above 60%, and a first half-year of positive EBITDA. Crucially, the quality of the customer base has changed: Newport News Shipbuilding — the largest US military shipbuilder — has committed to a fleet of six ARCEMY X systems, the US Navy's own additive manufacturing centre operates three AML3D machines, and repeat parts orders for obsolete submarine components point to an emerging recurring stream. The balance sheet, with A$26.7m of cash and no debt, removes near-term solvency risk.
Yet the market's scepticism is understandable. The share price has fallen roughly 57% over twelve months and trades at about 2.7x trailing EV/sales. Revenue remains lumpy, heavily concentrated in one country and a handful of Navy-funded buyers, and still too small to absorb a cost base that drove A$6.4m of free cash outflow in FY26. Profitability in 2H26 leaned on R&D tax offsets and interest income. Governance signals are mixed: a minority-independent board, routine unhurdled option grants to directors, a FY25 restatement accompanying an auditor change, and a founder who sold nearly all his stock before stepping back from the CTO role.
On balance, AML3D is a high-risk, high-optionality way to play US and AUKUS naval industrial-base modernisation. The investment case for the next 12 months hinges on three verifiable events: on-time delivery of the four remaining NNS systems, a first UK system order, and evidence that FY27 first-half revenue does not repeat the FY26 timing slump. If all three land, the current valuation likely understates the franchise; if two slip, the market will continue to price AML3D as a sub-scale, cash-consuming equipment vendor.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Independence | Background / education | Committees |
|---|---|---|---|---|---|
Noel Cornish AM | Non-executive Chairman | 5 Oct 2022 | Independent | B.Sc, M.Eng.Sc, FAICD. Former Chief Executive of BlueScope's Australian and NZ businesses; President of North Star BHP LLC (Ohio, USA); former chair of Snowy Hydro and IMB Bank; former National President of Ai Group; currently chair of Hunter Valley Coal Chain and Pro Chancellor, University of Newcastle; AM (2017). Career began with a BHP Steel cadetship in 1969. | Chair, Remuneration & Nomination; member, Audit & Risk |
Sean Ebert | Managing Director & CEO | Director 30 Aug 2019; MD & CEO 18 Sep 2023 | Not independent | B.Eng (Hons, Electrical), MAICD. 25+ years in executive roles; former Global Director M&A at Worley; former CEO of Camms and Profit Impact; NED of FCT International and MLEI Consulting Engineers; former director of Mighty Craft (resigned 20 Jul 2024). Interim AML3D chair Nov 2021 – Oct 2022. | — |
Andrew Sales | Non-executive Director (founder) | Director 14 Nov 2014; MD 2014–2022; CTO 26 Sep 2022 – 5 Aug 2026 | Not independent | M.Eng, M.Sc, C.Eng (ECUK/TWI), CMatP. Welding technology expert with ~29 years of global experience in oil and gas, resources, heavy fabrication; author of technical papers on welding corrosion-resistant alloys; sits on two Standards Australia committees including additive manufacturing. | Member, Audit & Risk; member, Remuneration & Nomination |
Peter Siebels | Non-executive Director | 15 Jan 2024 | Independent | B.Ec, FCA, FAICD. ~30-year KPMG career incl. Australian National Board; former chair of RAA, RAA Insurance, Electricity Industry Superannuation Scheme, Hood Sweeney, Robern Menz; NED roles at ECH, Adelaide University, GCF Investments. | Chair, Audit & Risk; member, Remuneration & Nomination |
Executive Leadership Team
| Name | Title | Tenure | Notes |
|---|---|---|---|
Sean Ebert | Managing Director & CEO | CEO since 18 Sep 2023 | Executive services agreement: max 3-year term (from Sep 2023, i.e., renewal due around Sep 2026 — extension status not disclosed); STI up to 30% of base; LTI up to 40% of base in performance rights on 30% TSR CAGR over three years |
Hamish McEwin | CFO and COO | Full year FY26 (start date not disclosed) | STI up to 30%; LTI up to 40% |
Pete Goumas | President, AML3D USA Inc. | Full year FY26 (joined ~2023) | Fixed remuneration US$300k at 2023 grant; STI 30%, LTI 40% |
Andrew Sales | CTO (to 5 Aug 2026) | 2022–2026 | No STI/LTI as CTO; now NED |
Jeremy Thomas | Global Vice President of Sales | — | Named on aggregator listings; not KMP |
Kaitlin Smith | Company Secretary | Since 30 Nov 2022 | Outsourced company secretarial/accounting provider |
“—” = not publicly disclosed.
Directors' Remuneration
| Name | Salary & fees | STI | Leave accruals | Super / 401(k) | Performance rights | Options | Total | % at risk |
|---|---|---|---|---|---|---|---|---|
Noel Cornish (Chair) | 100,000 | 0 | 0 | 12,000 | 0 | 206,000 | 318,000 | 0% |
Peter Siebels (NED) | 60,000 | 0 | 0 | 7,200 | 0 | 206,000 | 273,200 | 0% |
Sean Ebert (MD & CEO) | 422,016 | 114,021 | 16,311 | 50,642 | 108,484 | 206,000 | 917,474 | 24% |
Andrew Sales (CTO) | 268,121 | 0 | -745 | 22,362 | 0 | 206,000 | 495,738 | 0% |
Hamish McEwin (CFO/COO) | 308,792 | 83,430 | 12,481 | 37,055 | 32,780 | 0 | 474,538 | 24% |
Pete Goumas (President US) | 485,343 | 67,477 | 31,141 | 20,758 | 63,407 | 0 | 668,126 | 20% |
Total KMP | 1,644,272 | 264,928 | 59,188 | 150,017 | 204,671 | 824,000 | 3,147,076 | — |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Nov 2021 | Stephen Gerlach AM steps down as chair; Ebert interim chair | Board renewal post-IPO |
26 Sep 2022 | Ryan Millar CEO; Sales to CTO | Separation of founder from CEO role to professionalise commercialisation |
5 Oct 2022 | Noel Cornish appointed chair | Brought steel-industry and US (Ohio) operating experience |
22 Nov 2022 | Leonard Piro leaves board | — |
18 Sep 2023 | Ebert becomes MD & CEO; Millar exits | Coincided with acceleration of US strategy |
15 Jan 2024 | Peter Siebels joins as independent NED | Strengthened audit/finance oversight |
6 Feb 2026 | ASX "Change in Director Role" announcement | — |
5 Aug 2026 | Sales steps down as CTO; becomes non-independent NED | Founder transition; technical leadership succession not detailed |
FY26 | Auditor change to KPMG | Prior auditor issued FY25 opinion; FY25 restated |
Major Shareholders
| Holder | Stake | Date / source | Comment |
|---|---|---|---|
Regal Funds Management and associates | Substantial (≥5%) on 24 Dec 2024 | Form 603, 30 Dec 2024 | — |
Perennial Value Management | 10.1% (Feb 2021) | ASX Feb 2021 | IPO cornerstone; current holding not publicly disclosed in sources reviewed |
Andrew Sales (founder) | 550,000 shares (~0.1%) at 30 Jun 2026 | FY26 Remuneration Report | Sold 25.66m shares in FY26; ceased substantial holder Sep 2025 |
All directors combined | 4.34m shares (~0.8%) | FY26 AR | Plus 26m options and 3.89m performance rights |
Pete Goumas | 3.0m shares | FY26 AR | — |
Competitive Landscape
Key Competitors
| Competitor | HQ / listing | Technology | Overlap with AML3D | Scale indicator |
|---|---|---|---|---|
Lincoln Electric (Additive Solutions) | US; NASDAQ: LECO | WAAM (large-format wire-arc parts and services) | Direct — US defence/energy large parts; also a welding consumables giant | — |
WAAM3D | UK (Cranfield spin-out); private | WAAM systems (RoboWAAM) and software | Direct — UK/Europe WAAM systems | — |
MX3D | Netherlands; private | Robotic WAAM systems and software | Direct — systems for marine/energy | — |
Gefertec | Germany; private | Arc-based 3D metal printers (arc605 etc.) | Direct — European WAAM machines | — |
Sciaky (Phillips Service Industries) | US; private | Electron-beam additive manufacturing (EBAM), wire-fed | Adjacent — large titanium/defence parts | — |
NoINR K Titanium | Norway; Oslo: NTI | Rapid Plasma Deposition (wire-fed DED) | Adjacent — aerospace/defence titanium parts | FY2025 revenue US$4.06m; net loss US$55.9m (Stock Analysis) |
Titomic | Australia; ASX: TTT | Cold spray additive manufacturing | Adjacent — US defence, maritime sustainment | 1H CY2026 revenue A$4.87m; net loss A$19.35m (company/Quartr summary) |
SPEE3D | Australia; private | Supersonic cold-spray deposition, deployable/expeditionary | Adjacent — portable defence manufacturing (competes with portable ARCEMY) | — |
Meltio | Spain; private | Wire-laser metal deposition | Adjacent — smaller wire-fed DED cells | — |
Conventional foundries / forge shops | Global | Casting, forging | Substitute — incumbent supply for NAB/CuNi parts | Large, fragmented |
Powder-bed metal AM OEMs (Nikon SLM, EOS, Velo3D, 3D Systems) | Various | Laser powder-bed fusion | Indirect — smaller, finer parts; also bid for Navy AM | Hundreds of US$m revenue (varies) |
“—” = not publicly disclosed.
Peer Comparison FY2026
| Metric | AML3D (FY26, A$) | NoINR K Titanium (FY2025, US$) | Titomic (1H CY2026, A$) |
|---|---|---|---|
Revenue | 12.47m | 4.06m | 4.87m (half-year) |
Revenue growth YoY | +69% | −20% | −11% |
Gross margin | 63% | Negative | Not disclosed in summary |
Net margin | −36% | −1,377% | ~−397% |
R&D intensity | 11% of revenue (P&L R&D line) | — | — |
Cash | 26.7m | — | 14.3m (30 Jun 2026) |
“—” = not publicly disclosed.
Recent Developments
The company stated it was not party to any proceedings in FY26.



